{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:00:44Z","timestamp":1790744444373,"version":"4.1.0"},"reference-count":101,"publisher":"Archives of Endocrinology and Metabolism","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,16]]},"DOI":"10.20945\/2359-3997000000557","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T12:19:09Z","timestamp":1668687549000},"page":"678-688","source":"Crossref","is-referenced-by-count":14,"title":["Surgery for primary hyperparathyroidism"],"prefix":"10.20945","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8094-6298","authenticated-orcid":false,"given":"Murilo Catafesta das","family":"Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1172-4621","authenticated-orcid":false,"given":"Rodrigo Oliveira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-7185","authenticated-orcid":false,"given":"Monique Nakayama","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"10","key":"key20221117071902_B1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959-68.","journal-title":"JAMA Surg"},{"issue":"3","key":"key20221117071902_B2","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122-9.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20221117071902_B3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00423-021-02173-1","article-title":"Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK)","volume":"406","author":"Weber","year":"2021","unstructured":"Weber T, Dotzenrath C, Dralle H, Niederle B, Riss P, Holzer K, et al. Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK). Langenbecks Arch Surg. 2021;406(3):571-85.","journal-title":"Langenbecks Arch Surg"},{"issue":"10","key":"key20221117071902_B4","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Udelsman","year":"2014","unstructured":"Udelsman R, \u00c5kerstr\u00f6m G, Biagini C, Duh QY, Miccoli P, Niederle B, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3595-606.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key20221117071902_B5","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561-9.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key20221117071902_B6","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Eastell","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D\u2019Amour P, Shoback DM, Thakker R v. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3570-9.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20221117071902_B7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1590\/S0100-879X2005000900013","article-title":"Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in S\u00e3o Paulo from 1985 to 2002","volume":"38","author":"Ohe","year":"2005","unstructured":"Ohe MN, Santos RO, Barros ER, Lage A, Kunii IS, Abrah\u00e3o M, et al. Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in S\u00e3o Paulo from 1985 to 2002. Braz J Med Biol Res. 2005;38(9):1383-7.","journal-title":"Braz J Med Biol Res"},{"issue":"10116","key":"key20221117071902_B8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391(10116):168-78.","journal-title":"Lancet"},{"issue":"69","key":"key20221117071902_B9","doi-asserted-by":"crossref","first-page":"S13147","DOI":"10.4137\/CMED.S13147","article-title":"Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil","volume":"6","author":"Eufrazino","year":"2013","unstructured":"Eufrazino C, Veras A, Bandeira F. Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil. Clin Med Insights Endocrinol Diabetes. 2013;6(69):S13147.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"11","key":"key20221117071902_B10","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1007\/s00268-009-9962-0","article-title":"Remedial operation for primary hyperparathyroidism","volume":"33","author":"Prescott","year":"2009","unstructured":"Prescott JD, Udelsman R. Remedial operation for primary hyperparathyroidism. World J Surg. 2009;33(11):2324-34.","journal-title":"World J Surg"},{"issue":"4","key":"key20221117071902_B11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3803\/EnM.2019.34.4.327","article-title":"Intraoperative parathyroid hormone monitoring in the surgical management of sporadic primary hyperparathyroidism","volume":"34","author":"Khan","year":"2019","unstructured":"Khan ZF, Lew JI. Intraoperative parathyroid hormone monitoring in the surgical management of sporadic primary hyperparathyroidism. Endocrinol Metab (Seoul). 2019;34(4):327-39.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"5","key":"key20221117071902_B12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000658-200205000-00008","article-title":"Six hundred fifty-six consecutive explorations for primary hyperparathyroidism","volume":"235","author":"Udelsman","year":"2002","unstructured":"Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235(5):665-72.","journal-title":"Ann Surg"},{"issue":"2","key":"key20221117071902_B13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archsurg.137.2.186","article-title":"Measurement of intraoperative parathyroid hormone predicts long-term operative success","volume":"137","author":"Westerdahl","year":"2002","unstructured":"Westerdahl J, Lindblom P, Bergenfelz A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg. 2002;137(2):186-90.","journal-title":"Arch Surg"},{"issue":"5","key":"key20221117071902_B14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.sla.0000124448.49794.74","article-title":"Progress in the operative management of sporadic primary hyperparathyroidism over 34 years","volume":"239","author":"Irvin","year":"2004","unstructured":"Irvin GL 3rd, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239(5):704-11.","journal-title":"Ann Surg"},{"issue":"4","key":"key20221117071902_B15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.surg.2005.06.046","article-title":"Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy","volume":"138","author":"Chen","year":"2005","unstructured":"Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138(4):583-90.","journal-title":"Surgery"},{"issue":"5","key":"key20221117071902_B16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/archsurg.140.5.472","article-title":"Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinical experience","volume":"140","author":"Grant","year":"2005","unstructured":"Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinical experience. Arch Surg. 2005;140(5):472-9.","journal-title":"Arch Surg"},{"issue":"5","key":"key20221117071902_B17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1148\/rg.2020190190","article-title":"Parathyroid 4D CT: What the Surgeon Wants to Know","volume":"40","author":"Bunch","year":"2020","unstructured":"Bunch PM, Randolph GW, Brooks JA, George V, Cannon J, Kelly HR. Parathyroid 4D CT: What the Surgeon Wants to Know. Radiographics. 2020;40(5):1383-94.","journal-title":"Radiographics"},{"key":"key20221117071902_B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28:1-19.","journal-title":"Osteoporos Int"},{"issue":"6","key":"key20221117071902_B19","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.surg.2016.11.019","article-title":"The utility of repeat sestamibi scans in patients with primary hyperparathyroidism after an initial negative scan","volume":"161","author":"Krishnamurthy","year":"2017","unstructured":"Krishnamurthy VD, Sound S, Okoh AK, Yazici P, Yigitbas H, Neumann D, et al. The utility of repeat sestamibi scans in patients with primary hyperparathyroidism after an initial negative scan. Surgery. 2017;161(6):1651-8.","journal-title":"Surgery"},{"issue":"1","key":"key20221117071902_B20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.surg.2016.05.048","article-title":"Influence of a negative sestamibi scan on the decision for parathyroid operation by the endocrinologist and surgeon","volume":"161","author":"Wu","year":"2017","unstructured":"Wu S, Hwang SS, Haigh PI. Influence of a negative sestamibi scan on the decision for parathyroid operation by the endocrinologist and surgeon. Surgery. 2017;161(1):35-43.","journal-title":"Surgery"},{"issue":"9","key":"key20221117071902_B21","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","article-title":"The EANM practice guidelines for parathyroid imaging","volume":"48","author":"Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Giovanella L, Carri\u00f3 Gasset I, Hindi\u00e9 E, Huellner MW, Luster M, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801-22.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"key20221117071902_B22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/bjs.12025","article-title":"European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism","volume":"108","author":"Bergenfelz","year":"2021","unstructured":"Bergenfelz A, van Slycke S, Makay, Brunaud L. European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism. Br J Surg. 2021;108(6):675-83.","journal-title":"Br J Surg"},{"issue":"3","key":"key20221117071902_B23","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/clinem\/dgab740","article-title":"Correlation of preoperative imaging findings and parathyroidectomy outcomes support NICE 2019 guidance","volume":"107","author":"Chander","year":"2022","unstructured":"Chander NR, Chidambaram S, van den Heede K, Dimarco AN, Tolley NS, Palazzo FF. Correlation of preoperative imaging findings and parathyroidectomy outcomes support NICE 2019 guidance. J Clin Endocrinol Metab. 2022;107(3):E1242-8.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20221117071902_B24","first-page":"139","article-title":"Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years","volume":"176","author":"Untch","year":"2011","unstructured":"Untch BR, Adam MA, Scheri RP, Bennett KM, Dixit D, Webb C, et al. Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg. 2011;176(5):139-48.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"key20221117071902_B25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jamcollsurg.2005.08.014","article-title":"Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism","volume":"202","author":"Solorzano","year":"2006","unstructured":"Solorzano CC, Carneiro-Pla DM, Irvin GL. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg. 2006;202(1):18-24.","journal-title":"J Am Coll Surg"},{"issue":"2","key":"key20221117071902_B26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1148\/radiol.2019182122","article-title":"Diagnostic performance of 4D CT and sestamibi SPECT\/CT in localizing parathyroid adenomas in primary hyperparathyroidism","volume":"291","author":"Yeh","year":"2019","unstructured":"Yeh R, Tay YK, Tabacco G, Dercle L, Kuo JH, Bandeira L, et al. Diagnostic performance of 4D CT and sestamibi SPECT\/CT in localizing parathyroid adenomas in primary hyperparathyroidism. Radiology. 2019;291(2):469-76.","journal-title":"Radiology"},{"issue":"3","key":"key20221117071902_B27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00259-018-4123-z","article-title":"Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis","volume":"46","author":"Treglia","year":"2019","unstructured":"Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46(3):751-65.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"key20221117071902_B28","doi-asserted-by":"crossref","DOI":"10.4322\/ahns.2019.0011","article-title":"Analysis of PTH serum concentration from internal jugular veins of patients with primary hyperparathyroidism","volume":"48","author":"Ribeiro","year":"2019","unstructured":"Ribeiro DK, Lera MM, Fonseca ABR, Neves MC das. Analysis of PTH serum concentration from internal jugular veins of patients with primary hyperparathyroidism. Arch Head Neck Surg. 2019;48(2):e00222019.","journal-title":"Arch Head Neck Surg"},{"issue":"12","key":"key20221117071902_B29","doi-asserted-by":"crossref","first-page":"E963","DOI":"10.1002\/lary.28566","article-title":"Surgery versus imaging in non-localizing primary hyperparathyroidism: a cost-effectiveness model","volume":"130","author":"Frank","year":"2020","unstructured":"Frank E, Watson WA, Fujimoto S, de Andrade Filho P, Inman J, Simental A. Surgery versus imaging in non-localizing primary hyperparathyroidism: a cost-effectiveness model. Laryngoscope. 2020;130(12):E963-9.","journal-title":"Laryngoscope"},{"issue":"1","key":"key20221117071902_B30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40463-016-0178-7","article-title":"The dangers of parathyroid biopsy","volume":"46","author":"Kim","year":"2017","unstructured":"Kim J, Horowitz G, Hong M, Orsini M, Asa SL, Higgins K. The dangers of parathyroid biopsy. J Otolaryngol Head Neck Surg. 2017;46(1):4.","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"6","key":"key20221117071902_B31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00423-006-0095-8","article-title":"Implantation of parathyroid carcinoma along fine needle aspiration track","volume":"391","author":"Agarwal","year":"2006","unstructured":"Agarwal G, Dhingra S, Mishra SK, Krishnani N. Implantation of parathyroid carcinoma along fine needle aspiration track. Langenbecks Arch Surg. 2006;391(6):623-6.","journal-title":"Langenbecks Arch Surg"},{"issue":"12","key":"key20221117071902_B32","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/thy.2007.0081","article-title":"Diagnostic aspiration of parathyroid adenomas causes severe fibrosis complicating surgery and final histologic diagnosis","volume":"17","author":"Norman","year":"2007","unstructured":"Norman J, Politz D, Browarsky I. Diagnostic aspiration of parathyroid adenomas causes severe fibrosis complicating surgery and final histologic diagnosis. Thyroid. 2007;17(12):1251-5.","journal-title":"Thyroid"},{"issue":"8","key":"key20221117071902_B33","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","unstructured":"Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987;33(8):1364-7.","journal-title":"Clin Chem"},{"issue":"4","key":"key20221117071902_B34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9610(91)90135-Z","article-title":"Operative monitoring of parathyroid gland hyperfunction","volume":"162","author":"Irvin","year":"1991","unstructured":"Irvin GL 3rd, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg. 1991;162(4):299-302.","journal-title":"Am J Surg"},{"issue":"6","key":"key20221117071902_B35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.surg.2003.06.001","article-title":"Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: Which criterion is the most accurate?","volume":"134","author":"Carneiro","year":"2003","unstructured":"Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL, Udelsman R, et al. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: Which criterion is the most accurate? Surgery. 2003;134(6):973-9.","journal-title":"Surgery"},{"issue":"10","key":"key20221117071902_B36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archsurg.1996.01430220068015","article-title":"Ambulatory parathyroidectomy for primary hyperparathyroidism","volume":"131","author":"Irvin","year":"1996","unstructured":"Irvin GL 3rd, Sfakianakis G, Yeung L, Deriso GT, Fishman LM, Molinari AS, et al. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg. 1996;131(10):1074-8.","journal-title":"Arch Surg"},{"issue":"5","key":"key20221117071902_B37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00000658-199405000-00015","article-title":"A new approach to parathyroidectomy","volume":"219","author":"Irvin","year":"1994","unstructured":"Irvin GL 3rd, Prudhomme DL, Deriso GT, Sfakianakis G, Chandarlapaty SK. A new approach to parathyroidectomy. Ann Surg. 1994;219(5):574-81.","journal-title":"Ann Surg"},{"key":"key20221117071902_B38","doi-asserted-by":"crossref","first-page":"914214","DOI":"10.1155\/2012\/914214","article-title":"A 10-year experience in intraoperative parathyroid hormone measurements for primary hyperparathyroidism: A prospective study of 91 previous unexplored patients","volume":"2012","author":"Neves","year":"2012","unstructured":"Neves MC, Ohe MN, Rosano M, Abrah\u00e3o M, Cervantes O, Lazaretti-Castro M, et al. A 10-year experience in intraoperative parathyroid hormone measurements for primary hyperparathyroidism: A prospective study of 91 previous unexplored patients. J Osteoporos. 2012;2012:914214.","journal-title":"J Osteoporos"},{"issue":"6","key":"key20221117071902_B39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1590\/S0100-879X2003000600006","article-title":"Usefulness of a rapid immunometric assay for intraoperative parathyroid hormone measurements","volume":"36","author":"Ohe","year":"2003","unstructured":"Ohe MN, Santos RO, Kunii IS, Carvalho AB, Abrah\u00e3o M, Cervantes O, et al. Usefulness of a rapid immunometric assay for intraoperative parathyroid hormone measurements. Braz J Med Biol Res. 2003;36(6):715-21.","journal-title":"Braz J Med Biol Res"},{"issue":"9-10","key":"key20221117071902_B40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.clinbiochem.2006.12.007","article-title":"Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point","volume":"40","author":"di Stasio","year":"2007","unstructured":"di Stasio E, Carrozza C, Pio Lombardi C, Raffaelli M, Traini E, Bellantone R, et al. Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point. Clin Biochem. 2007;40(9-10):595-603.","journal-title":"Clin Biochem"},{"issue":"3","key":"key20221117071902_B41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/archsurg.2011.5","article-title":"An optimal algorithm for intraoperative parathyroid hormone monitoring","volume":"146","author":"Richards","year":"2011","unstructured":"Richards ML, Thompson GB, Farley DR, Grant CS. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg. 2011;146(3):280-5.","journal-title":"Arch Surg"},{"issue":"5","key":"key20221117071902_B42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00423-009-0510-z","article-title":"Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy","volume":"394","author":"Barczynski","year":"2009","unstructured":"Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W. Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg. 2009;394(5):843-9.","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"key20221117071902_B43","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1067\/msy.2002.128695","article-title":"Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism","volume":"132","author":"Carneiro","year":"2002","unstructured":"Carneiro DM, Irvin GL 3rd, Inabnet WB. Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. Surgery. 2002;132(6):1050-4; discussion 1055.","journal-title":"Surgery"},{"issue":"3","key":"key20221117071902_B44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.surg.2007.05.004","article-title":"A \u201cdefined baseline\u201d in PTH monitoring increases surgical success in patients with multiple gland disease","volume":"142","author":"Riss","year":"2007","unstructured":"Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B. A \u201cdefined baseline\u201d in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery. 2007;142(3):398-404.","journal-title":"Surgery"},{"issue":"5","key":"key20221117071902_B45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00423-008-0384-5","article-title":"Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease","volume":"393","author":"Lombardi","year":"2008","unstructured":"Lombardi CP, Raffaelli M, Traini E, di Stasio E, Carrozza C, de Crea C, et al. Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbecks Arch Surg. 2008;393(5):639-45.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"key20221117071902_B46","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00268-010-0887-4","article-title":"Intraoperative parathyroid hormone monitoring in patients with recognized multiglandular primary hyperparathyroidism","volume":"35","author":"Hughes","year":"2011","unstructured":"Hughes DT, Miller BS, Doherty GM, Gauger PG. Intraoperative parathyroid hormone monitoring in patients with recognized multiglandular primary hyperparathyroidism. World J Surg. 2011;35(2):336-41.","journal-title":"World J Surg"},{"issue":"1","key":"key20221117071902_B47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00405-018-5179-x","article-title":"Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up?","volume":"276","author":"Sartori","year":"2019","unstructured":"Sartori PV, Saibene AM, Leopaldi E, Boniardi M, Beretta E, Colombo S, et al. Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up? Eur Arch Otorhinolaryngol. 2019;276(1):267-72.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"key20221117071902_B48","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2265.2007.02827.x","article-title":"Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging","volume":"66","author":"Barczynski","year":"2007","unstructured":"Barczynski M, Konturek A, Cichon S, Hubalewska-Dydejczyk A, Golkowski F, Huszno B. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol. 2007;66(6):878-85.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"key20221117071902_B49","doi-asserted-by":"crossref","first-page":"18804","DOI":"10.1038\/s41598-020-75856-2","article-title":"Establish pre-clinical diagnostic efficacy for parathyroid hormone as a point-of-surgery-testing-device (POST)","volume":"10","author":"Tanak","year":"2020","unstructured":"Tanak AS, Muthukumar S, Hashim IA, Prasad S. Establish pre-clinical diagnostic efficacy for parathyroid hormone as a point-of-surgery-testing-device (POST). Sci Rep. 2020;10(1):18804.","journal-title":"Sci Rep"},{"issue":"3","key":"key20221117071902_B50","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00268-009-0100-9","article-title":"Symposium on evidence-based endocrine surgery (3: hyperparathyroidism)","volume":"33","author":"Akerstr\u00f6m","year":"2009","unstructured":"Akerstr\u00f6m G. Symposium on evidence-based endocrine surgery (3: hyperparathyroidism). World J Surg. 2009;33(3):2219-23.","journal-title":"World J Surg"},{"issue":"4","key":"key20221117071902_B51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s42000-020-00195-w","article-title":"Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society","volume":"19","author":"Makras","year":"2020","unstructured":"Makras P, Yavropoulou MP, Kassi E, Anastasilakis AD, Vryonidou A, Tournis S. Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society. Hormones. 2020;19(4):581-91.","journal-title":"Hormones"},{"issue":"5","key":"key20221117071902_B52","first-page":"593","article-title":"Primary hyperparathyroidism. Best practice and research","volume":"32","author":"Silva","year":"2018","unstructured":"Silva BC, Cusano NE, Bilezikian JP. Primary hyperparathyroidism. Best practice and research. Clin Endocr Metab. 2018;32(5):593-607.","journal-title":"Clin Endocr Metab"},{"issue":"9","key":"key20221117071902_B53","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH Study)","volume":"32","author":"Lundstam","year":"2017","unstructured":"Lundstam K, Heck A, Godang K, Mollerup C, Baranowski M, Pernow Y, et al. Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH Study). J Bone Miner Res. 2017;32(9):1907-14.","journal-title":"J Bone Miner Res"},{"key":"key20221117071902_B54","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","unstructured":"Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F. Primary hyperparathyroidism. Nat Rev Dis Primers. 2016;2:16033.","journal-title":"Nat Rev Dis Primers"},{"key":"key20221117071902_B55","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00268-022-06485-1","article-title":"Neuropsychiatric comorbidity in primary hyperparathyroidism before and after parathyroidectomy: a population study","volume":"46","author":"Koman","year":"2022","unstructured":"Koman A, Br\u00e4nstr\u00f6m R, Pernow Y, Br\u00e4nstr\u00f6m R, Nilsson IL, Granath F. Neuropsychiatric comorbidity in primary hyperparathyroidism before and after parathyroidectomy: a population study. World J Surg. 2022;46:1420-30.","journal-title":"World J Surg"},{"issue":"1","key":"key20221117071902_B56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"19","author":"Beysel","year":"2019","unstructured":"Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M, et al. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord. 2019;19(1):1-8.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"key20221117071902_B57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13304-017-0477-1","article-title":"Updates in primary hyperparathyroidism","volume":"69","author":"Gasparri","year":"2017","unstructured":"Gasparri G. Updates in primary hyperparathyroidism. Updates Surg. 2017;69(2):217-23.","journal-title":"Updates Surg"},{"issue":"4","key":"key20221117071902_B58","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jamcollsurg.2018.12.034","article-title":"Bilateral neck exploration for sporadic primary hyperparathyroidism: use patterns in 5,597 patients undergoing parathyroidectomy in the collaborative endocrine surgery quality improvement program","volume":"228","author":"Kiernan","year":"2019","unstructured":"Kiernan CM, Wang T, Perrier ND, Grubbs EG, Sol\u00f3rzano CC. Bilateral neck exploration for sporadic primary hyperparathyroidism: use patterns in 5,597 patients undergoing parathyroidectomy in the collaborative endocrine surgery quality improvement program. J Am Coll Surg. 2019;228(4):652-9.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"key20221117071902_B59","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00423-009-0540-6","article-title":"Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients","volume":"394","author":"Bergenfelz","year":"2009","unstructured":"Bergenfelz AOJ, Jansson SKG, Wallin GK, M\u00e5rtensson HG, Rasmussen L, Eriksson HLO, et al. Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients. Langenbecks Arch Surg. 2009;394(5):851-60.","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"key20221117071902_B60","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archsurg.141.8.777","article-title":"Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model","volume":"141","author":"Kebebew","year":"2006","unstructured":"Kebebew E, Hwang J, Reiff E, Duh QY, Clark OH. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg. 2006;141(8):777-82.","journal-title":"Arch Surg"},{"issue":"1","key":"key20221117071902_B61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5005\/jp-journals-10002-1199","article-title":"The CaPTHUS scoring model revisited: applicability from a UK cohort with primary hyperparathyroidism","volume":"9","author":"James","year":"2017","unstructured":"James TW, Stechman MJ, Scott-Coombes DM. The CaPTHUS scoring model revisited: applicability from a UK cohort with primary hyperparathyroidism. World J Endocr Surg. 2017;9(1):7-12.","journal-title":"World J Endocr Surg"},{"issue":"3","key":"key20221117071902_B62","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jamcollsurg.2011.12.007","article-title":"Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations","volume":"214","author":"Norman","year":"2012","unstructured":"Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg. 2012;214(3):260-9.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"key20221117071902_B63","first-page":"438","article-title":"Primary hyperparathyroidism: diagnosis and management in 2017","volume":"127","author":"Syed","year":"2017","unstructured":"Syed H, Khan A. Primary hyperparathyroidism: diagnosis and management in 2017. Pol Arch Intern Med. 2017;127(6):438-41.","journal-title":"Pol Arch Intern Med"},{"issue":"S1","key":"key20221117071902_B64","doi-asserted-by":"crossref","first-page":"E300","DOI":"10.1002\/hed.23990","article-title":"Long-term prospective evaluation comparing robotic parathyroidectomy with minimally invasive open parathyroidectomy for primary hyperparathyroidism","volume":"38","author":"Tolley","year":"2016","unstructured":"Tolley N, Garas G, Palazzo F, Prichard A, Chaidas K, Cox J, et al. Long-term prospective evaluation comparing robotic parathyroidectomy with minimally invasive open parathyroidectomy for primary hyperparathyroidism. Head Neck. 2016;38(S1):E300-6.","journal-title":"Head Neck"},{"key":"key20221117071902_B65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijsu.2015.01.019","article-title":"Is robotic parathyroidectomy a feasible and safe alternative to targeted open parathyroidectomy for the treatment of primary hyperparathyroidism?","volume":"15","author":"Garas","year":"2015","unstructured":"Garas G, Holsinger FC, Grant DG, Athanasiou T, Arora A, Tolley N. Is robotic parathyroidectomy a feasible and safe alternative to targeted open parathyroidectomy for the treatment of primary hyperparathyroidism? Int J Surg. 2015;15:55-60.","journal-title":"Int J Surg"},{"issue":"11","key":"key20221117071902_B66","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","unstructured":"Silverberg SJ, Bilezikian JP. \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J Clin Endocrinol Metab. 2003;88(11):5348-52.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key20221117071902_B67","doi-asserted-by":"crossref","first-page":"e2609","DOI":"10.1210\/clinem\/dgaa174","article-title":"Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism","volume":"105","author":"Palermo","year":"2020","unstructured":"Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, et al. Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab. 2020;105(7):e2609-16.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20221117071902_B68","doi-asserted-by":"crossref","first-page":"E1171","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History","volume":"105","author":"Schini","year":"2020","unstructured":"Schini M, Jacques RM, Oakes E, Peel NFA, Walsh JS, Eastell R. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History. J Clin Endocrinol Metab. 2020;105(4):E1171-86.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key20221117071902_B69","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","article-title":"Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations","volume":"98","author":"Cusano","year":"2013","unstructured":"Cusano NE, Maalouf NM, Wang PY, Zhang C, Cremers SC, Haney EM, et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab. 2013;98(7):2734-41.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20221117071902_B70","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","article-title":"Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women","volume":"42","author":"Garc\u00eda-Mart\u00edn","year":"2012","unstructured":"Garc\u00eda-Mart\u00edn A, Reyes-Garc\u00eda R, Mu\u00f1oz-Torres M. Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women. Endocrine. 2012;42(3):764-6.","journal-title":"Endocrine"},{"issue":"6","key":"key20221117071902_B71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MED.0000000000000198","article-title":"An overview of normocalcemic primary hyperparathyroidism","volume":"22","author":"Pawlowska","year":"2015","unstructured":"Pawlowska M, Cusano NE. An overview of normocalcemic primary hyperparathyroidism. Curr Opin Endocrinol Diabetes Obes. 2015;22(6):413-21.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"key20221117071902_B72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","article-title":"Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?","volume":"55","author":"Marques","year":"2011","unstructured":"Marques TF, Vasconcelos R, Diniz E, R\u00eago D, Griz L, Bandeira F. Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat? Arq Bras Endocrinol Metabol. 2011;55(5):314-7.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"5","key":"key20221117071902_B73","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/cen.14315","article-title":"Normocalcaemic primary hyperparathyroidism: an update on diagnostic and management challenges","volume":"93","author":"Dawood","year":"2022","unstructured":"Dawood NB, Yan KL, Shieh A, Livhits MJ, Yeh MW, Leung AM. Normocalcaemic primary hyperparathyroidism: an update on diagnostic and management challenges. Clin Endocrinol (Oxford). 2022;93(5):519-27.","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"10","key":"key20221117071902_B74","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00268-016-3514-1","article-title":"Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis","volume":"40","author":"Singh Ospina","year":"2016","unstructured":"Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, Espinosa de Ycaza AE, Jasim S, Castaneda-Guarderas A, et al. Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg. 2016;40(10):2359-77.","journal-title":"World J Surg"},{"issue":"1","key":"key20221117071902_B75","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.surg.2019.06.043","article-title":"Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis","volume":"167","author":"Pandian","year":"2020","unstructured":"Pandian TK, Lubitz CC, Bird SH, Kuo LE, Stephen AE. Normocalcemic hyperparathyroidism: a collaborative endocrine surgery quality improvement program analysis. Surgery. 2020;167(1):168-72.","journal-title":"Surgery"},{"issue":"4","key":"key20221117071902_B76","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00268-018-4512-2","article-title":"Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?","volume":"42","author":"Kiriakopoulos","year":"2018","unstructured":"Kiriakopoulos A, Petralias A, Linos D. Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ? World J Surg. 2018;42(4):992-7.","journal-title":"World J Surg"},{"issue":"1","key":"key20221117071902_B77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.surg.2016.08.054","article-title":"Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism","volume":"161","author":"Lim","year":"2017","unstructured":"Lim JY, Herman MC, Bubis L, Epelboym I, Allendorf JD, Chabot JA, et al. Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery. 2017;161(1):70-7.","journal-title":"Surgery"},{"issue":"8","key":"key20221117071902_B78","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","unstructured":"Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E, et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab. 2013;98(8):3213-20.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20221117071902_B79","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0194599818793879","article-title":"Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome","volume":"159","author":"Trinh","year":"2018","unstructured":"Trinh G, Rettig E, Noureldine SI, Russell JO, Agrawal N, Mathur A, et al. Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome. Oto Laryngeal Head Neck Surgery. 2018;159(4):630-7.","journal-title":"Oto Laryngeal Head Neck Surgery"},{"issue":"6","key":"key20221117071902_B80","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","article-title":"Management of normocalcemic primary hyperparathyroidism","volume":"32","author":"Cusano","year":"2018","unstructured":"Cusano NE, Cipriani C, Bilezikian JP. Management of normocalcemic primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):837-45.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"key20221117071902_B81","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4158\/EP15704.OR","article-title":"Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat?","volume":"22","author":"\u0160iprov\u00e1","year":"2016","unstructured":"\u0160iprov\u00e1 H, Fry\u0161\u00e1k Z, Sou\u010dek M. Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat? Endocr Pract. 2016;22(3):294-301.","journal-title":"Endocr Pract"},{"issue":"7","key":"key20221117071902_B82","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00423-017-1617-2","article-title":"Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm","volume":"402","author":"G\u00f3mez-Ram\u00edrez","year":"2017","unstructured":"G\u00f3mez-Ram\u00edrez J, Mihai R. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm. Langenbecks Arch Surg. 2017;402(7):1103-8.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"key20221117071902_B83","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1245\/s10434-018-6998-0","article-title":"Biochemical and Skeletal Outcomes of Parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism","volume":"26","author":"Sho","year":"2019","unstructured":"Sho S, Kuo EJ, Chen AC, Li N, Yeh MW, Livhits MJ. Biochemical and Skeletal Outcomes of Parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism. Ann Surg Oncol. 2019;26(2):539-46.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"key20221117071902_B84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12020-021-02845-4","article-title":"A practical approach to normocalcemic primary hyperparathyroidism","volume":"74","author":"Mu\u00f1oz de Nova","year":"2021","unstructured":"Mu\u00f1oz de Nova JL, Sampedro-Nu\u00f1ez M, Huguet-Moreno I, Marazuela Azpiroz M. A practical approach to normocalcemic primary hyperparathyroidism. Endocrine. 2021;74(2):235-44.","journal-title":"Endocrine"},{"issue":"2","key":"key20221117071902_B85","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)","volume":"186","author":"Bollerslev","year":"2022","unstructured":"Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Eur J Endocrinol. 2022;186(2):R33-63.","journal-title":"Eur J Endocrinol"},{"issue":"13","key":"key20221117071902_B86","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10132956","article-title":"Primary hyperparathyroidism in pregnancy: literature review of the diagnosis and management","volume":"10","author":"Ali","year":"2021","unstructured":"Ali DS, Dandurand K, Khan AA. Primary hyperparathyroidism in pregnancy: literature review of the diagnosis and management. J Clin Med. 2021;10(13).","journal-title":"J Clin Med"},{"issue":"6","key":"key20221117071902_B87","first-page":"1024","article-title":"Primary hyperparathyroidism during pregnancy","volume":"110","author":"Kelly","year":"1991","unstructured":"Kelly TR. Primary hyperparathyroidism during pregnancy. Surgery. 1991;110(6):1024-8.","journal-title":"Surgery"},{"issue":"7","key":"key20221117071902_B88","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/archsurg.2010.104","article-title":"Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients","volume":"145","author":"Lew","year":"2010","unstructured":"Lew JI, Rivera M, Irvin GL, Solorzano CC. Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients. Arch Surg. 2010;145(7):628-33.","journal-title":"Arch Surg"},{"issue":"3","key":"key20221117071902_B89","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjsurg.2017.01.012","article-title":"Predictors of operative failure in parathyroidectomy for primary hyperparathyroidism","volume":"214","author":"Cron","year":"2017","unstructured":"Cron DC, Kapeles SR, Andraska EA, Kwon ST, Kirk PS, McNeish BL, et al. Predictors of operative failure in parathyroidectomy for primary hyperparathyroidism. Am J Surg. 2017;214(3):509-14.","journal-title":"Am J Surg"},{"key":"key20221117071902_B90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000491039","article-title":"Parathyroid Carcinoma","volume":"51","author":"Cetani","year":"2018","unstructured":"Cetani F, Pardi E, Marcocci C. Parathyroid Carcinoma. Front Horm Res. 2018;51:63-76.","journal-title":"Front Horm Res"},{"issue":"2","key":"key20221117071902_B91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.suronc.2014.03.005","article-title":"Parathyroid carcinoma","volume":"23","author":"Al-Kurd","year":"2014","unstructured":"Al-Kurd A, Mekel M, Mazeh H. Parathyroid carcinoma. Surg Oncol. 2014;23(2):107-14.","journal-title":"Surg Oncol"},{"issue":"6","key":"key20221117071902_B92","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clon.2010.04.007","article-title":"Parathyroid carcinoma","volume":"22","author":"Givi","year":"2010","unstructured":"Givi B, Shah JP. Parathyroid carcinoma. Clin Oncol. 2010;22(6):498-507.","journal-title":"Clin Oncol"},{"issue":"2","key":"key20221117071902_B93","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00268-010-0840-6","article-title":"Clinical and histopathological characteristics of hyperparathyroidism- induced hypercalcemic crisis","volume":"35","author":"Starker","year":"2011","unstructured":"Starker LF, Bj\u00f6rklund P, Theoharis C, Long WD, Carling T, Udelsman R. Clinical and histopathological characteristics of hyperparathyroidism- induced hypercalcemic crisis. World J Surg. 2011;35(2):331-5.","journal-title":"World J Surg"},{"issue":"11","key":"key20221117071902_B94","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00268-009-9999-0","article-title":"Parathyroid carcinoma: etiology, diagnosis, and treatment","volume":"33","author":"Okamoto","year":"2009","unstructured":"Okamoto T, Iihara M, Obara T, Tsukada T. Parathyroid carcinoma: etiology, diagnosis, and treatment. World J Surg. 2009;33(11):2343-54.","journal-title":"World J Surg"},{"issue":"1","key":"key20221117071902_B95","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1245\/s10434-020-08825-8","article-title":"The use and benefit of adjuvant radiotherapy in parathyroid carcinoma: a national cancer database analysis","volume":"28","author":"Limberg","year":"2021","unstructured":"Limberg J, Stefanova D, Ullmann TM, Thiesmeyer JW, Bains S, Beninato T, et al. The use and benefit of adjuvant radiotherapy in parathyroid carcinoma: a national cancer database analysis. Ann Surg Oncol. 2021;28(1):502-11.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"key20221117071902_B96","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.lpm.2018.03.005","article-title":"Update on multiple endocrine neoplasia type 1 and 2","volume":"47","author":"Al-Salameh","year":"2018","unstructured":"Al-Salameh A, Baudry C, Cohen R. Update on multiple endocrine neoplasia type 1 and 2. Presse Med. 2018;47(9):722-31.","journal-title":"Presse Med"},{"issue":"4","key":"key20221117071902_B97","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cen.14727","article-title":"Update on the clinical management of multiple endocrine neoplasia type 1","volume":"97","author":"Pieterman","year":"2022","unstructured":"Pieterman CRC, Valk GD. Update on the clinical management of multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2022;97(4):409-23.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20221117071902_B98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): An update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","unstructured":"Kamilaris CDC, Stratakis CA. Multiple endocrine neoplasia type 1 (MEN1): An update and the significance of early genetic and clinical diagnosis. Front Endocrinol (Lausanne). 2019;10:1-15.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"key20221117071902_B99","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s00268-017-4366-z","article-title":"Impact of \u201ctailored\u201d parathyroidectomy for treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"42","author":"Horiuchi","year":"2018","unstructured":"Horiuchi K, Sakurai M, Haniu K, Nagai E, Tokumitsu H, Yoshida Y, et al. Impact of \u201ctailored\u201d parathyroidectomy for treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. World J Surg. 2018;42(6):1772-8.","journal-title":"World J Surg"},{"key":"key20221117071902_B100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fendo.2019.00123","article-title":"Could the less-than subtotal parathyroidectomy be an option for treating young patients with multiple endocrine neoplasia type 1-related hyperparathyroidism?","volume":"10","author":"Montenegro","year":"2019","unstructured":"Montenegro FL de M, Brescia MDG, Louren\u00e7o DMJ, Arap SS, d\u2019Alessandro AF, de Britto E Silva Filho G, et al. Could the less-than subtotal parathyroidectomy be an option for treating young patients with multiple endocrine neoplasia type 1-related hyperparathyroidism? Front Endocrinol (Lausanne). 2019;10:123.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20221117071902_B101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-319-22542-5_8","article-title":"Primary hyperparathyroidism in MEN2 syndromes","volume":"204","author":"Alevizaki","year":"2015","unstructured":"Alevizaki M, Saltiki K. Primary hyperparathyroidism in MEN2 syndromes. Recent Results Cancer Res. 2015;204:179-86.","journal-title":"Recent Results Cancer Res"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T12:20:29Z","timestamp":1668687629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/surgery-for-primary-hyperparathyroidism\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,16]]}},"alternative-id":["10.20945\/2359-3997000000557"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000557","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}